Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Agonists for Male Infertility
NCT07179120Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2026
- Primary completion
- Aug 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, open-label trial of semaglutide and tirzepatide in male infertility and obesity (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Change from Baseline in Sperm Concentration at 32 weeks. Planned start May 2026; status: not yet recruiting.
02
Drugs
03
Conditions
male infertilityobesity
Beyond the preview
Go deeper on NCT07179120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07179120.